Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study

Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study

Abstract Objectives The objective of the study is to compare the efficacy and safety of alternative androgen therapy (AAT) with enzalutamide + androgen deprivation therapy (ADT) and flutamide + ADT in the treatment of Japanese men with metastatic or nonmetastatic castration‐resistant prostate cancer...

Full description

Bibliographic Details
Main Authors: Hiroji Uemura, Kazuki Kobayashi, Akira Yokomizo, Shiro Hinotsu, Shigeo Horie, Yoshiyuki Kakehi, Seiji Naito, Norio Nonomura, Osamu Ogawa, Mototsugu Oya, Kazuhiro Suzuki, Atsushi Saito, Satoshi Uno, Hideyuki Akaza
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:BJUI Compass
Subjects:
AFTERCAB
alternative androgen therapy
androgen deprivation therapy
bicalutamide
castration‐resistant prostate cancer
combined androgen blockade
Online Access:https://doi.org/10.1002/bco2.103

Internet

https://doi.org/10.1002/bco2.103

Similar Items